Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors

  • Francesco Merlino
  • , Yang Zhou
  • , Minying Cai
  • , Alfonso Carotenuto
  • , Ali M. Yousif
  • , Diego Brancaccio
  • , Salvatore Di Maro
  • , Silvia Zappavigna
  • , Antonio Limatola
  • , Ettore Novellino
  • , Paolo Grieco
  • , Victor J. Hruby

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.

Original languageEnglish (US)
Pages (from-to)4263-4269
Number of pages7
JournalJournal of Medicinal Chemistry
Volume61
Issue number9
DOIs
StatePublished - May 10 2018

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors'. Together they form a unique fingerprint.

Cite this